Strong test results
The active ingredients in Diabatrol's proprietary formulation are whole grain derivatives that have been clinically tested and documented to lower blood glucose levels and reduce insulin resistance. In a 60-day, double-blind, randomized trial, which have been published in the Journal of Nutritional Biochemistry, the results were very promising: Type II diabetes test subjects realized an average 32.9 percent reduction (52 points) in fasting blood glucose levels. These results are comparable to many pharmaceutical drugs. In addition, an impressive secondary result included an 8 percent reduction in low-density lipoprotein (LDL), an important consideration for diabetic at-risk individuals concerned with high blood pressure and heart problems.
Considering Diabatrol's positive showing thus far in decreasing insulin resistance and providing a balanced level of overall nutrition, every indication is that this product provides a positive answer for a more simplified approach to the daily routines associated with diabetes management programs.
Diabco Life Sciences, LLC
The company's mission is to provide effective neutraceutical supplements for consumers seeking performance proven non-prescription alternatives to help mitigate specific health risks. Diabco Life Sciences strives to combine advanced science, nutrition and good manufacturing practices to bring clinically tested and scientifically documented products to market for meeting the daily healthcare needs of individuals. More information about the company can be found at http://www.healthydiabetic.com, or by writing to Diabco Life Sciences, 484 East Carmel Drive, #204, Carmel, Indiana, 46032.'/>"/>
Copyright©2007 PR Newswire.
All rights reserved